Correction to: “Comments on Injectable Estradiol Use in Transgender and Gender-diverse Individuals in the United States” - Top-Institutions - MDSpire

Correction to: “Comments on Injectable Estradiol Use in Transgender and Gender-diverse Individuals in the United States”

  • January 7, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    The Fenway Institute
    The Fenway Institute

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Transgender Health
    • HIV and LGBTQ+ Health

  • #2

    UCSF Center of Excellence for Transgender Health
    UCSF Center of Excellence for Transgender Health

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Transgender Medicine
    • Public Health

  • #3

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Endocrinology
    • Transgender Medicine
    • Clinical Research

  • #4

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Transgender Health
    • Clinical Trials

  • #5

    University of California, Los Angeles (UCLA) Center for Transgender Health
    University of California, Los Angeles (UCLA) Center for Transgender Health

    Los Angeles, CA

    Key Differentiators

    • Endocrinology
    • Transgender Medicine
    • Behavioral Health

Original Source(s)

Correction to: “Comments on Injectable Estradiol Use in Transgender and Gender-diverse Individuals in the United States”

  • January 7, 2026

Related Content

Wearables May Boost T2D Mobility

Outpatient intervention combined physiotherapist counseling with wrist-worn activity monitoring.

Texas is opening up a detransition clinic

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.